Acetylcysteine Solution (N-acetyl-L-cysteine) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 4, 2017 Category: Drugs & Pharmacology Source Type: news
A girl with self-harm treated with N-acetylcysteine (NAC) - Rus CP.
Deliberate and recurrent self-harm could be regarded as addictive behaviour that can be treated with medication. In addiction, the dopaminergic mesolimbic reward system is activated. Pain caused by cutting stimulates the reward system through the opioid sy... (Source: SafetyLit)
Source: SafetyLit - March 31, 2017 Category: Global & Universal Tags: Suicide and Self-Harm Source Type: news
Do not get a serum acetaminophen level less than 4 hours after an acute ingestion
4 out of 5 stars
Can a serum acetaminophen concentration obtained less than 4 hours post-ingestion determine which patients do not require treatment with acetylcysteine? Yarema MC et al. Clin Toxicol 2017 Feb;55:102-108.
Abstract
For decades the decision whether or not to treat acute acetaminophen [APAP] toxicity with N-acetylcysteine (NAC) has been guided by a serum APAP level drawn 4 or more hours after ingestion. The thought was that before 4 hours the level might be misleading because absorption of the drug might not be complete.
This paper addresses the question of whether an earlier level can be sufficient to clea...
Source: The Poison Review - February 9, 2017 Category: Toxicology Authors: Leon Gussow Tags: Medical acetaminophen antidote APAP N-acetylcysteine rumack-matthew nomogram treatment Source Type: news
A potential pharmaceutical intervention for co-occurring PTSD and substance use disorder
(Medical University of South Carolina) Veterans with co-occurring PTSD and substance abuse disorder (SUD) who received the antioxidant N-acetylcysteine in addition to group cognitive behavioral therapy (CBT) for their SUD had fewer PTSD symptoms and less craving and depression than those who underwent CBT alone, according to the findings of a randomized, controlled pilot trial recently reported by researchers at the Medical University of South Carolina and the Ralph H. Johnson VA Medical Center in the Journal of Clinical Psychiatry. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 16, 2016 Category: Global & Universal Source Type: news
N-acetylcysteine shows early promise in reducing alcohol use in marijuana-dependent teens
N-acetylcysteine (NAC) reduced alcohol use in a small cohort of marijuana-dependent adolescents who exhibited reductions in marijuana use, report researchers. In this secondary analysis of data from an earlier trial of NAC in marijuana-dependent adolescents, researchers show that reduced marijuana use was associated with reductions in alcohol consumption in the NAC-treated, but not placebo-treated teens. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - December 14, 2016 Category: Science Source Type: news
N-acetylcysteine shows early promise in reducing alcohol use in marijuana-dependent teens
(Medical University of South Carolina) N-acetylcysteine (NAC) reduced alcohol use in a small cohort of marijuana-dependent adolescents who exhibited reductions in marijuana use, report researchers at the Medical University of South Carolina in the December 2016 Addictive Behaviors. In this secondary analysis of data from an earlier trial of NAC in marijuana-dependent adolescents, MUSC researchers show that reduced marijuana use was associated with reductions in alcohol consumption in the NAC-treated, but not placebo-treated teens. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 14, 2016 Category: Global & Universal Source Type: news
The Use of N-Acetylcysteine in Acetaminophen Overdose The Use of N-Acetylcysteine in Acetaminophen Overdose
Explore alternative methods for the delivery of N-acetylcysteine to reduce hepatotoxicity in acetaminophen poisoning.Pediatric Pharmacotherapy (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 23, 2016 Category: Consumer Health News Tags: Pediatrics Journal Article Source Type: news
Glutathione Benefits: Boosting Levels For Long, Healthy Life
Many people who live to be 100 or more have something in common. And it’s not that they’ve followed conventional “wisdom” about healthy diet and exercise.
It’s that their bodies make more of a powerful antioxidant called glutathione than the average person.
It’s what keeps them from being ravaged by the toxic world we live in.
Glutathione is an important antioxidant produced by the body
By now you know your body is under attack every day from the air you breathe, the chemicals you use, and the processed foods you eat. These toxins cause your body to produce free radicals.
Here’s w...
Source: Al Sears, MD Natural Remedies - September 2, 2016 Category: Complementary Medicine Authors: Al Sears Tags: Health Source Type: news
ESC: Is N-acetylcysteine the Key to Reducing Infarct Size? (CME/CE)
(MedPage Today) -- Pilot study shows benefit as measured by MRI (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - August 29, 2016 Category: Cardiology Source Type: news
NACIAM: N-Acetylcysteine Reduces Infarct Size NACIAM: N-Acetylcysteine Reduces Infarct Size
The addition of intravenous N-acetylcysteine to GTN reduced infarct size by approximately one third and doubled myocardial salvage in STEMI patients in this phase 2 study.Heartwire from Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - August 28, 2016 Category: Cardiology Tags: Cardiology News Source Type: news
Naciam: N-acetylcysteine offers a post-MI boost
The addition of intravenous (IV) N-acetylcysteine (NAC) to IV glyceryl trinitrate (GTN) significantly reduced infarct size by approximately one third in patients undergoing percutaneous coronary intervention (PCI) after ST-segment elevation acute myocardial infarction (STEMI), according to Hot Line research reported here. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - August 28, 2016 Category: Science Source Type: news
Acetaminophen Overdose Antidote Cetylev Recalled Acetaminophen Overdose Antidote Cetylev Recalled
Arbor Pharmaceuticals recalls three lots of acetylcysteine (Cetylev) effervescent tablets for oral solution because of an inadequate seal of the blister pack.News Alerts (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - August 19, 2016 Category: Drugs & Pharmacology Tags: Emergency Medicine News Alert Source Type: news
Voluntary Nationwide Recall of Cetylev ® (Acetylcysteine) Effervescent Tablets for Oral Solution Due to an Inadequate Seal of the Blister Pack
Arbor Pharmaceuticals, LLC (Arbor) today announced a voluntary recall of three (3) lots of Cetylev (acetylcysteine) effervescent tablets for oral solution, 500 mg, due to an inadequate seal of the blister pack. An inadequate seal could result in an increase of oxygen and moisture entering the blister cavity which can start the effervescent process. This results in enlarged and swelled tablets which could also completely dissolve within the blister pack. (Source: Food and Drug Administration)
Source: Food and Drug Administration - August 18, 2016 Category: Food Science Source Type: news
Voluntary Nationwide Recall of Cetylev ® (Acetylcysteine) Effervescent Tablets for Oral Solution Due to an Inadequate Seal of the Blister Pack
Arbor Pharmaceuticals, LLC (Arbor) today announced a voluntary recall of three (3) lots of Cetylev (acetylcysteine) effervescent tablets for oral solution, 500 mg, due to an inadequate seal of the blister pack. An inadequate seal could result in an increase of oxygen and moisture entering the blister cavity which can start the effervescent process. This results in enlarged and swelled tablets which could also completely dissolve within the blister pack. (Source: Food and Drug Administration)
Source: Food and Drug Administration - August 18, 2016 Category: Food Science Source Type: news
The role of N-acetylcysteine in the management of COPD: A review of recent literature
(Bentham Science Publishers) Recent studies indicate the clinical significant effects of N-Acetylcysteine such as reducing exacerbation frequency are seen at daily doses 1,200 mg or greater. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 3, 2016 Category: Global & Universal Source Type: news
